595024032: OrbusNeich Jade 018 PTA Balloon Dilatation Catheter 5.0mm x 240mm, 200cm

Sign in to add this product to your favorites!
| Price: | $99.00 $69.30 per box of 1 |
|---|---|
| Quantity: | |
| In Stock: | 1 box of 1 |
| Status: | expired |
| Express: | Need it tomorrow? Order in next 13 hours 51 minutes and choose overnight shipping at checkout for Monday delivery. If you require Saturday delivery, please call to determine if it is available in your area - 888-416-2409. |
AccessGUDID Info
- FDA Product Code: LIT
- FDA Product Code Name: Catheter, Angioplasty, Peripheral, Transluminal
- GMDN Term Code: 17184
- GMDN Term Name: Peripheral angioplasty balloon catheter, basic
- GMDN Term Description: A sterile, non-drug-eluting, flexible tube designed for percutaneous transluminal angioplasty (PTA) to dilate a stenotic peripheral (i.e., non-cerebral, non-coronary) artery by controlled inflation of a distensible balloon(s) at its distal tip; it may also be intended for positioning and expansion of a stent/stent-graft. It is available as an over-the-wire (OTW) type with multiple lumens, or a rapid exchange (RX) type with a single lumen. Some types may include cutting/scoring elements (e.g., microsurgical blades, dual wire configurations) to score/modify the plaque. This is a single-use device.
Manufacturer
OrbusNeich is a global medical device company specializing in vascular intervention solutions. The company offers a comprehensive range of products for the treatment of coronary artery disease, peripheral artery disease, and other vascular conditions. OrbusNeich is best known for its drug-eluting stents (DES), including the Genous and Combostents, which combine drug delivery with biocompatible coatings to reduce restenosis rates. The company also provides a wide variety of balloon angioplasty devices, guidewires, catheters, and access systems used in interventional cardiology and vascular surgery. With a focus on innovative technologies, OrbusNeich aims to improve patient outcomes and procedural efficiency in the treatment of vascular diseases.
IN-DATE